Acute Atomoxetine Selectively Modulates Encoding of Reward Value in Ventral Medial Prefrontal Cortex
Background: A recent neurocognitive model of attention-deficit hyperactivity disorder (ADHD) has proposed a primary deficit in reward function as well as in executive function to account for underlying neural substrates of ADHD symptoms. Atomoxetine has been widely used as a non-stimulant medication...
Saved in:
Published in | Journal of Nippon Medical School Vol. 86; no. 2; pp. 98 - 107 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Japan
The Medical Association of Nippon Medical School
2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!